Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-grail-bio.jpg" NAME"Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million" ALT"Backed by Amazon and Big Names Like Bristol-Myers…

Continue ReadingBacked by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million

Scientists, Here???s the Best Elevator Pitch to Sell Yourself to a Potential Employer

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-scientist-best-elevator-pitch-employer.jpg" NAME"Scientists, Heres the Best Elevator Pitch to Sell Yourself to a Potential Employer" ALT"Scientists, Heres the Best Elevator Pitch to Sell Yourself to a Potential Employer"March 2, 2017By…

Continue ReadingScientists, Here???s the Best Elevator Pitch to Sell Yourself to a Potential Employer

Juno Finally Drops Problem CAR-T Drug That Caused Deaths

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-juno-hans-bishop.jpg" NAME"Juno Finally Drops Problem CAR-T Drug That Caused Deaths" ALT"Juno Finally Drops Problem CAR-T Drug That Caused Deaths"March 2, 2017By Alex Keown, BioSpace.com Breaking News StaffSEATTLE... Source: BioSpace

Continue ReadingJuno Finally Drops Problem CAR-T Drug That Caused Deaths

Genentech New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche Stock Soars

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-genentech.jpg" NAME"Genentech New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche Stock Soars" ALT"Genentech New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche Stock Soars"March…

Continue ReadingGenentech New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche Stock Soars